Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Chicoine, Daniel. Insider active across 2 companies, notably Crescita Therapeutics Inc.. Aggregated, 12 reports have been logged. Breakdown: 9 buys · 0 sell. Total volume traded: €885k. History available since 3 June 2026. The latest transaction was disclosed on 15 June 2026 (36 - Conversion or exchange). Regulator: SEDI. The full history is openly available.
Companies and markets linked to Chicoine, Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
645,999 shares@ CA$0.80100.0% of flowCommon SharesTSXSEDI:4732037
Canonical exit: 1 Sept 2026 (T+90)
12 of 12 declarations
About Chicoine, Daniel
Daniel Chicoine is a declarant linked to Crescita Therapeutics Inc. and NeuPath Health Inc., where he is identified as 4 - Director of Issuer, 5 - Senior Officer of Issuer for the first company and 4 - Director of Issuer for the second. The 12 filings on record, all within the sampled set, concern acquisitions, with 885472 EUR of buys and 0 EUR of sells between 2026-06-08 and 2026-06-15, and the largest published filings relate to Crescita Therapeutics Inc.